nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ankylosing spondylitis—Paget's disease of bone	0.402	0.506	CtDrD
Methotrexate—bone cancer—Paget's disease of bone	0.393	0.494	CtDrD
Methotrexate—ABCC1—Zoledronate—Paget's disease of bone	0.0745	1	CbGbCtD
Methotrexate—FOLR1—Folate Metabolism—CSF1—Paget's disease of bone	0.00311	0.215	CbGpPWpGaD
Methotrexate—SLC19A1—Folate Metabolism—CSF1—Paget's disease of bone	0.00124	0.0854	CbGpPWpGaD
Methotrexate—SLC46A1—Folate Metabolism—CSF1—Paget's disease of bone	0.000819	0.0566	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—CSF1—Paget's disease of bone	0.000494	0.0341	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—CSF1—Paget's disease of bone	0.000439	0.0303	CbGpPWpGaD
Methotrexate—Liver function test abnormal—Pamidronate—Paget's disease of bone	0.000349	0.00301	CcSEcCtD
Methotrexate—Osteoarthritis—Zoledronate—Paget's disease of bone	0.000346	0.00298	CcSEcCtD
Methotrexate—Haemoglobin—Alendronate—Paget's disease of bone	0.000345	0.00297	CcSEcCtD
Methotrexate—Asthma—Risedronate—Paget's disease of bone	0.000344	0.00296	CcSEcCtD
Methotrexate—Haemorrhage—Alendronate—Paget's disease of bone	0.000343	0.00296	CcSEcCtD
Methotrexate—Abdominal discomfort—Risedronate—Paget's disease of bone	0.00033	0.00284	CcSEcCtD
Methotrexate—Erythema multiforme—Alendronate—Paget's disease of bone	0.000325	0.00279	CcSEcCtD
Methotrexate—Anaemia—Etidronic acid—Paget's disease of bone	0.000324	0.00279	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.00032	0.00275	CcSEcCtD
Methotrexate—TYMS—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.000318	0.022	CbGpPWpGaD
Methotrexate—Leukopenia—Etidronic acid—Paget's disease of bone	0.000314	0.0027	CcSEcCtD
Methotrexate—Pneumonia—Risedronate—Paget's disease of bone	0.000309	0.00266	CcSEcCtD
Methotrexate—Infestation NOS—Risedronate—Paget's disease of bone	0.000307	0.00264	CcSEcCtD
Methotrexate—Infestation—Risedronate—Paget's disease of bone	0.000307	0.00264	CcSEcCtD
Methotrexate—Depression—Risedronate—Paget's disease of bone	0.000306	0.00263	CcSEcCtD
Methotrexate—Neutropenia—Pamidronate—Paget's disease of bone	0.000306	0.00263	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.000304	0.00262	CcSEcCtD
Methotrexate—Alopecia—Alendronate—Paget's disease of bone	0.000303	0.00261	CcSEcCtD
Methotrexate—Erythema—Alendronate—Paget's disease of bone	0.000299	0.00257	CcSEcCtD
Methotrexate—Asthma—Zoledronate—Paget's disease of bone	0.000299	0.00257	CcSEcCtD
Methotrexate—Arthralgia—Etidronic acid—Paget's disease of bone	0.000299	0.00257	CcSEcCtD
Methotrexate—Conjunctivitis—Risedronate—Paget's disease of bone	0.000298	0.00257	CcSEcCtD
Methotrexate—Discomfort—Etidronic acid—Paget's disease of bone	0.000295	0.00254	CcSEcCtD
Methotrexate—Pneumonia—Pamidronate—Paget's disease of bone	0.000293	0.00253	CcSEcCtD
Methotrexate—Dysgeusia—Alendronate—Paget's disease of bone	0.000293	0.00252	CcSEcCtD
Methotrexate—Infestation NOS—Pamidronate—Paget's disease of bone	0.000292	0.00251	CcSEcCtD
Methotrexate—Infestation—Pamidronate—Paget's disease of bone	0.000292	0.00251	CcSEcCtD
Methotrexate—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00029	0.0025	CcSEcCtD
Methotrexate—Confusional state—Etidronic acid—Paget's disease of bone	0.000289	0.00249	CcSEcCtD
Methotrexate—Renal failure—Pamidronate—Paget's disease of bone	0.000287	0.00247	CcSEcCtD
Methotrexate—Abdominal discomfort—Zoledronate—Paget's disease of bone	0.000286	0.00247	CcSEcCtD
Methotrexate—Infection—Etidronic acid—Paget's disease of bone	0.000284	0.00245	CcSEcCtD
Methotrexate—Stomatitis—Pamidronate—Paget's disease of bone	0.000284	0.00245	CcSEcCtD
Methotrexate—Pancytopenia—Zoledronate—Paget's disease of bone	0.000284	0.00244	CcSEcCtD
Methotrexate—Conjunctivitis—Pamidronate—Paget's disease of bone	0.000283	0.00244	CcSEcCtD
Methotrexate—Neutropenia—Zoledronate—Paget's disease of bone	0.000279	0.00241	CcSEcCtD
Methotrexate—Haematuria—Pamidronate—Paget's disease of bone	0.000278	0.00239	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.000278	0.00239	CcSEcCtD
Methotrexate—Ill-defined disorder—Alendronate—Paget's disease of bone	0.000277	0.00239	CcSEcCtD
Methotrexate—Haemoglobin—Risedronate—Paget's disease of bone	0.000277	0.00238	CcSEcCtD
Methotrexate—Anaemia—Alendronate—Paget's disease of bone	0.000276	0.00238	CcSEcCtD
Methotrexate—Haemorrhage—Risedronate—Paget's disease of bone	0.000275	0.00237	CcSEcCtD
Methotrexate—Pharyngitis—Risedronate—Paget's disease of bone	0.000273	0.00235	CcSEcCtD
Methotrexate—Agranulocytosis—Pamidronate—Paget's disease of bone	0.000272	0.00234	CcSEcCtD
Methotrexate—Urinary tract disorder—Risedronate—Paget's disease of bone	0.000272	0.00234	CcSEcCtD
Methotrexate—Urethral disorder—Risedronate—Paget's disease of bone	0.00027	0.00233	CcSEcCtD
Methotrexate—PGD—NRF2 pathway—SQSTM1—Paget's disease of bone	0.00027	0.0186	CbGpPWpGaD
Methotrexate—Malaise—Alendronate—Paget's disease of bone	0.000269	0.00232	CcSEcCtD
Methotrexate—Vertigo—Alendronate—Paget's disease of bone	0.000268	0.00231	CcSEcCtD
Methotrexate—Infestation—Zoledronate—Paget's disease of bone	0.000266	0.00229	CcSEcCtD
Methotrexate—Infestation NOS—Zoledronate—Paget's disease of bone	0.000266	0.00229	CcSEcCtD
Methotrexate—Depression—Zoledronate—Paget's disease of bone	0.000266	0.00229	CcSEcCtD
Methotrexate—Haemoglobin—Pamidronate—Paget's disease of bone	0.000263	0.00227	CcSEcCtD
Methotrexate—Renal failure—Zoledronate—Paget's disease of bone	0.000262	0.00226	CcSEcCtD
Methotrexate—Haemorrhage—Pamidronate—Paget's disease of bone	0.000262	0.00225	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.000261	0.00225	CcSEcCtD
Methotrexate—Stomatitis—Zoledronate—Paget's disease of bone	0.00026	0.00224	CcSEcCtD
Methotrexate—Conjunctivitis—Zoledronate—Paget's disease of bone	0.000259	0.00223	CcSEcCtD
Methotrexate—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.000259	0.00223	CcSEcCtD
Methotrexate—Eye disorder—Risedronate—Paget's disease of bone	0.000257	0.00222	CcSEcCtD
Methotrexate—Paraesthesia—Etidronic acid—Paget's disease of bone	0.000257	0.00221	CcSEcCtD
Methotrexate—Tinnitus—Risedronate—Paget's disease of bone	0.000257	0.00221	CcSEcCtD
Methotrexate—Urethral disorder—Pamidronate—Paget's disease of bone	0.000257	0.00221	CcSEcCtD
Methotrexate—Cardiac disorder—Risedronate—Paget's disease of bone	0.000256	0.0022	CcSEcCtD
Methotrexate—Myalgia—Alendronate—Paget's disease of bone	0.000254	0.00219	CcSEcCtD
Methotrexate—Chest pain—Alendronate—Paget's disease of bone	0.000254	0.00219	CcSEcCtD
Methotrexate—Haematuria—Zoledronate—Paget's disease of bone	0.000254	0.00219	CcSEcCtD
Methotrexate—Dyspepsia—Etidronic acid—Paget's disease of bone	0.000252	0.00217	CcSEcCtD
Methotrexate—Discomfort—Alendronate—Paget's disease of bone	0.000251	0.00216	CcSEcCtD
Methotrexate—Angiopathy—Risedronate—Paget's disease of bone	0.00025	0.00215	CcSEcCtD
Methotrexate—Immune system disorder—Risedronate—Paget's disease of bone	0.000249	0.00214	CcSEcCtD
Methotrexate—Agranulocytosis—Zoledronate—Paget's disease of bone	0.000249	0.00214	CcSEcCtD
Methotrexate—Mediastinal disorder—Risedronate—Paget's disease of bone	0.000248	0.00214	CcSEcCtD
Methotrexate—Eye disorder—Pamidronate—Paget's disease of bone	0.000245	0.00211	CcSEcCtD
Methotrexate—Cardiac disorder—Pamidronate—Paget's disease of bone	0.000243	0.00209	CcSEcCtD
Methotrexate—Infection—Alendronate—Paget's disease of bone	0.000242	0.00209	CcSEcCtD
Methotrexate—Mental disorder—Risedronate—Paget's disease of bone	0.000241	0.00208	CcSEcCtD
Methotrexate—Malnutrition—Risedronate—Paget's disease of bone	0.00024	0.00206	CcSEcCtD
Methotrexate—Angiopathy—Pamidronate—Paget's disease of bone	0.000238	0.00205	CcSEcCtD
Methotrexate—Immune system disorder—Pamidronate—Paget's disease of bone	0.000236	0.00204	CcSEcCtD
Methotrexate—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.000236	0.00203	CcSEcCtD
Methotrexate—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.000236	0.00203	CcSEcCtD
Methotrexate—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.000236	0.00203	CcSEcCtD
Methotrexate—Chills—Pamidronate—Paget's disease of bone	0.000235	0.00202	CcSEcCtD
Methotrexate—Urethral disorder—Zoledronate—Paget's disease of bone	0.000234	0.00202	CcSEcCtD
Methotrexate—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.000234	0.00202	CcSEcCtD
Methotrexate—Back pain—Risedronate—Paget's disease of bone	0.000232	0.002	CcSEcCtD
Methotrexate—Alopecia—Pamidronate—Paget's disease of bone	0.000231	0.00199	CcSEcCtD
Methotrexate—SLCO3A1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000231	0.0159	CbGpPWpGaD
Methotrexate—Malnutrition—Pamidronate—Paget's disease of bone	0.000228	0.00196	CcSEcCtD
Methotrexate—Erythema—Pamidronate—Paget's disease of bone	0.000228	0.00196	CcSEcCtD
Methotrexate—Urticaria—Etidronic acid—Paget's disease of bone	0.000227	0.00196	CcSEcCtD
Methotrexate—Abdominal pain—Etidronic acid—Paget's disease of bone	0.000226	0.00195	CcSEcCtD
Methotrexate—Eye disorder—Zoledronate—Paget's disease of bone	0.000223	0.00192	CcSEcCtD
Methotrexate—Dysgeusia—Pamidronate—Paget's disease of bone	0.000223	0.00192	CcSEcCtD
Methotrexate—PGD—Carbohydrate metabolism—NUP205—Paget's disease of bone	0.000223	0.0154	CbGpPWpGaD
Methotrexate—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.000222	0.00191	CcSEcCtD
Methotrexate—Cardiac disorder—Zoledronate—Paget's disease of bone	0.000222	0.00191	CcSEcCtD
Methotrexate—Anaemia—Risedronate—Paget's disease of bone	0.000222	0.00191	CcSEcCtD
Methotrexate—Back pain—Pamidronate—Paget's disease of bone	0.00022	0.0019	CcSEcCtD
Methotrexate—SLCO4C1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.00022	0.0152	CbGpPWpGaD
Methotrexate—SLC16A1—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.000219	0.0151	CbGpPWpGaD
Methotrexate—Angiopathy—Zoledronate—Paget's disease of bone	0.000217	0.00187	CcSEcCtD
Methotrexate—Immune system disorder—Zoledronate—Paget's disease of bone	0.000216	0.00186	CcSEcCtD
Methotrexate—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.000216	0.00186	CcSEcCtD
Methotrexate—Vertigo—Risedronate—Paget's disease of bone	0.000215	0.00186	CcSEcCtD
Methotrexate—Dyspepsia—Alendronate—Paget's disease of bone	0.000215	0.00185	CcSEcCtD
Methotrexate—Chills—Zoledronate—Paget's disease of bone	0.000215	0.00185	CcSEcCtD
Methotrexate—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.000211	0.00182	CcSEcCtD
Methotrexate—Alopecia—Zoledronate—Paget's disease of bone	0.000211	0.00182	CcSEcCtD
Methotrexate—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.000211	0.00182	CcSEcCtD
Methotrexate—Anaemia—Pamidronate—Paget's disease of bone	0.000211	0.00181	CcSEcCtD
Methotrexate—Mental disorder—Zoledronate—Paget's disease of bone	0.000209	0.0018	CcSEcCtD
Methotrexate—Cough—Risedronate—Paget's disease of bone	0.000209	0.0018	CcSEcCtD
Methotrexate—Pain—Alendronate—Paget's disease of bone	0.000209	0.0018	CcSEcCtD
Methotrexate—Malnutrition—Zoledronate—Paget's disease of bone	0.000208	0.00179	CcSEcCtD
Methotrexate—Erythema—Zoledronate—Paget's disease of bone	0.000208	0.00179	CcSEcCtD
Methotrexate—Malaise—Pamidronate—Paget's disease of bone	0.000206	0.00177	CcSEcCtD
Methotrexate—Myalgia—Risedronate—Paget's disease of bone	0.000204	0.00176	CcSEcCtD
Methotrexate—Arthralgia—Risedronate—Paget's disease of bone	0.000204	0.00176	CcSEcCtD
Methotrexate—Chest pain—Risedronate—Paget's disease of bone	0.000204	0.00176	CcSEcCtD
Methotrexate—Leukopenia—Pamidronate—Paget's disease of bone	0.000204	0.00176	CcSEcCtD
Methotrexate—Dysgeusia—Zoledronate—Paget's disease of bone	0.000204	0.00176	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.000203	0.00175	CcSEcCtD
Methotrexate—Pruritus—Etidronic acid—Paget's disease of bone	0.000202	0.00174	CcSEcCtD
Methotrexate—Back pain—Zoledronate—Paget's disease of bone	0.000201	0.00173	CcSEcCtD
Methotrexate—Feeling abnormal—Alendronate—Paget's disease of bone	0.000201	0.00173	CcSEcCtD
Methotrexate—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.000199	0.00172	CcSEcCtD
Methotrexate—Cough—Pamidronate—Paget's disease of bone	0.000199	0.00171	CcSEcCtD
Methotrexate—Convulsion—Pamidronate—Paget's disease of bone	0.000197	0.0017	CcSEcCtD
Methotrexate—Vision blurred—Zoledronate—Paget's disease of bone	0.000196	0.00169	CcSEcCtD
Methotrexate—Diarrhoea—Etidronic acid—Paget's disease of bone	0.000196	0.00169	CcSEcCtD
Methotrexate—Infection—Risedronate—Paget's disease of bone	0.000194	0.00167	CcSEcCtD
Methotrexate—Arthralgia—Pamidronate—Paget's disease of bone	0.000194	0.00167	CcSEcCtD
Methotrexate—Myalgia—Pamidronate—Paget's disease of bone	0.000194	0.00167	CcSEcCtD
Methotrexate—Urticaria—Alendronate—Paget's disease of bone	0.000194	0.00167	CcSEcCtD
Methotrexate—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.000193	0.00166	CcSEcCtD
Methotrexate—Abdominal pain—Alendronate—Paget's disease of bone	0.000193	0.00166	CcSEcCtD
Methotrexate—Body temperature increased—Alendronate—Paget's disease of bone	0.000193	0.00166	CcSEcCtD
Methotrexate—Anaemia—Zoledronate—Paget's disease of bone	0.000192	0.00166	CcSEcCtD
Methotrexate—Nervous system disorder—Risedronate—Paget's disease of bone	0.000192	0.00165	CcSEcCtD
Methotrexate—Discomfort—Pamidronate—Paget's disease of bone	0.000192	0.00165	CcSEcCtD
Methotrexate—Skin disorder—Risedronate—Paget's disease of bone	0.00019	0.00164	CcSEcCtD
Methotrexate—Malaise—Zoledronate—Paget's disease of bone	0.000188	0.00162	CcSEcCtD
Methotrexate—Confusional state—Pamidronate—Paget's disease of bone	0.000188	0.00162	CcSEcCtD
Methotrexate—Vertigo—Zoledronate—Paget's disease of bone	0.000187	0.00161	CcSEcCtD
Methotrexate—ABCC11—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000187	0.0129	CbGpPWpGaD
Methotrexate—Leukopenia—Zoledronate—Paget's disease of bone	0.000186	0.0016	CcSEcCtD
Methotrexate—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.000186	0.0016	CcSEcCtD
Methotrexate—Infection—Pamidronate—Paget's disease of bone	0.000185	0.00159	CcSEcCtD
Methotrexate—SLCO1C1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000184	0.0127	CbGpPWpGaD
Methotrexate—Nervous system disorder—Pamidronate—Paget's disease of bone	0.000182	0.00157	CcSEcCtD
Methotrexate—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.000182	0.00157	CcSEcCtD
Methotrexate—Vomiting—Etidronic acid—Paget's disease of bone	0.000182	0.00157	CcSEcCtD
Methotrexate—Cough—Zoledronate—Paget's disease of bone	0.000182	0.00156	CcSEcCtD
Methotrexate—Rash—Etidronic acid—Paget's disease of bone	0.00018	0.00155	CcSEcCtD
Methotrexate—Convulsion—Zoledronate—Paget's disease of bone	0.00018	0.00155	CcSEcCtD
Methotrexate—Dermatitis—Etidronic acid—Paget's disease of bone	0.00018	0.00155	CcSEcCtD
Methotrexate—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00018	0.00155	CcSEcCtD
Methotrexate—Hypersensitivity—Alendronate—Paget's disease of bone	0.00018	0.00155	CcSEcCtD
Methotrexate—Headache—Etidronic acid—Paget's disease of bone	0.000179	0.00154	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.000178	0.00154	CcSEcCtD
Methotrexate—Anorexia—Pamidronate—Paget's disease of bone	0.000177	0.00153	CcSEcCtD
Methotrexate—Chest pain—Zoledronate—Paget's disease of bone	0.000177	0.00153	CcSEcCtD
Methotrexate—Myalgia—Zoledronate—Paget's disease of bone	0.000177	0.00153	CcSEcCtD
Methotrexate—Arthralgia—Zoledronate—Paget's disease of bone	0.000177	0.00153	CcSEcCtD
Methotrexate—Insomnia—Risedronate—Paget's disease of bone	0.000177	0.00152	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.000176	0.00152	CcSEcCtD
Methotrexate—Paraesthesia—Risedronate—Paget's disease of bone	0.000176	0.00151	CcSEcCtD
Methotrexate—Discomfort—Zoledronate—Paget's disease of bone	0.000175	0.00151	CcSEcCtD
Methotrexate—Asthenia—Alendronate—Paget's disease of bone	0.000175	0.00151	CcSEcCtD
Methotrexate—Dyspnoea—Risedronate—Paget's disease of bone	0.000174	0.0015	CcSEcCtD
Methotrexate—Hypotension—Pamidronate—Paget's disease of bone	0.000174	0.0015	CcSEcCtD
Methotrexate—Pruritus—Alendronate—Paget's disease of bone	0.000173	0.00149	CcSEcCtD
Methotrexate—Dyspepsia—Risedronate—Paget's disease of bone	0.000172	0.00148	CcSEcCtD
Methotrexate—Confusional state—Zoledronate—Paget's disease of bone	0.000171	0.00148	CcSEcCtD
Methotrexate—Nausea—Etidronic acid—Paget's disease of bone	0.00017	0.00146	CcSEcCtD
Methotrexate—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00017	0.00146	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.000169	0.00146	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.000169	0.00145	CcSEcCtD
Methotrexate—Infection—Zoledronate—Paget's disease of bone	0.000169	0.00145	CcSEcCtD
Methotrexate—Fatigue—Risedronate—Paget's disease of bone	0.000169	0.00145	CcSEcCtD
Methotrexate—Insomnia—Pamidronate—Paget's disease of bone	0.000168	0.00145	CcSEcCtD
Methotrexate—Pain—Risedronate—Paget's disease of bone	0.000167	0.00144	CcSEcCtD
Methotrexate—Paraesthesia—Pamidronate—Paget's disease of bone	0.000167	0.00144	CcSEcCtD
Methotrexate—Diarrhoea—Alendronate—Paget's disease of bone	0.000167	0.00144	CcSEcCtD
Methotrexate—Nervous system disorder—Zoledronate—Paget's disease of bone	0.000167	0.00143	CcSEcCtD
Methotrexate—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.000166	0.00143	CcSEcCtD
Methotrexate—Dyspnoea—Pamidronate—Paget's disease of bone	0.000166	0.00143	CcSEcCtD
Methotrexate—Somnolence—Pamidronate—Paget's disease of bone	0.000165	0.00142	CcSEcCtD
Methotrexate—Skin disorder—Zoledronate—Paget's disease of bone	0.000165	0.00142	CcSEcCtD
Methotrexate—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.000164	0.00141	CcSEcCtD
Methotrexate—Dyspepsia—Pamidronate—Paget's disease of bone	0.000164	0.00141	CcSEcCtD
Methotrexate—Anorexia—Zoledronate—Paget's disease of bone	0.000162	0.00139	CcSEcCtD
Methotrexate—Decreased appetite—Pamidronate—Paget's disease of bone	0.000162	0.00139	CcSEcCtD
Methotrexate—Dizziness—Alendronate—Paget's disease of bone	0.000161	0.00139	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.000161	0.00138	CcSEcCtD
Methotrexate—Fatigue—Pamidronate—Paget's disease of bone	0.00016	0.00138	CcSEcCtD
Methotrexate—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00016	0.00138	CcSEcCtD
Methotrexate—Pain—Pamidronate—Paget's disease of bone	0.000159	0.00137	CcSEcCtD
Methotrexate—Hypotension—Zoledronate—Paget's disease of bone	0.000159	0.00137	CcSEcCtD
Methotrexate—Urticaria—Risedronate—Paget's disease of bone	0.000155	0.00134	CcSEcCtD
Methotrexate—Vomiting—Alendronate—Paget's disease of bone	0.000155	0.00134	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.000155	0.00133	CcSEcCtD
Methotrexate—Body temperature increased—Risedronate—Paget's disease of bone	0.000155	0.00133	CcSEcCtD
Methotrexate—Abdominal pain—Risedronate—Paget's disease of bone	0.000155	0.00133	CcSEcCtD
Methotrexate—Rash—Alendronate—Paget's disease of bone	0.000154	0.00132	CcSEcCtD
Methotrexate—Insomnia—Zoledronate—Paget's disease of bone	0.000154	0.00132	CcSEcCtD
Methotrexate—Dermatitis—Alendronate—Paget's disease of bone	0.000154	0.00132	CcSEcCtD
Methotrexate—Feeling abnormal—Pamidronate—Paget's disease of bone	0.000153	0.00132	CcSEcCtD
Methotrexate—Headache—Alendronate—Paget's disease of bone	0.000153	0.00132	CcSEcCtD
Methotrexate—Paraesthesia—Zoledronate—Paget's disease of bone	0.000153	0.00131	CcSEcCtD
Methotrexate—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000152	0.00131	CcSEcCtD
Methotrexate—Dyspnoea—Zoledronate—Paget's disease of bone	0.000151	0.0013	CcSEcCtD
Methotrexate—Somnolence—Zoledronate—Paget's disease of bone	0.000151	0.0013	CcSEcCtD
Methotrexate—Dyspepsia—Zoledronate—Paget's disease of bone	0.00015	0.00129	CcSEcCtD
Methotrexate—Decreased appetite—Zoledronate—Paget's disease of bone	0.000148	0.00127	CcSEcCtD
Methotrexate—Body temperature increased—Pamidronate—Paget's disease of bone	0.000147	0.00127	CcSEcCtD
Methotrexate—Abdominal pain—Pamidronate—Paget's disease of bone	0.000147	0.00127	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000147	0.00126	CcSEcCtD
Methotrexate—Fatigue—Zoledronate—Paget's disease of bone	0.000146	0.00126	CcSEcCtD
Methotrexate—ABCC4—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.000146	0.0101	CbGpPWpGaD
Methotrexate—Pain—Zoledronate—Paget's disease of bone	0.000145	0.00125	CcSEcCtD
Methotrexate—Nausea—Alendronate—Paget's disease of bone	0.000145	0.00125	CcSEcCtD
Methotrexate—Hypersensitivity—Risedronate—Paget's disease of bone	0.000144	0.00124	CcSEcCtD
Methotrexate—Asthenia—Risedronate—Paget's disease of bone	0.00014	0.00121	CcSEcCtD
Methotrexate—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00014	0.00121	CcSEcCtD
Methotrexate—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000139	0.0012	CcSEcCtD
Methotrexate—Pruritus—Risedronate—Paget's disease of bone	0.000138	0.00119	CcSEcCtD
Methotrexate—Hypersensitivity—Pamidronate—Paget's disease of bone	0.000137	0.00118	CcSEcCtD
Methotrexate—SLC19A1—Disease—VCP—Paget's disease of bone	0.000136	0.00943	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—CSF1—Paget's disease of bone	0.000135	0.00932	CbGpPWpGaD
Methotrexate—Urticaria—Zoledronate—Paget's disease of bone	0.000135	0.00116	CcSEcCtD
Methotrexate—Abdominal pain—Zoledronate—Paget's disease of bone	0.000134	0.00116	CcSEcCtD
Methotrexate—Body temperature increased—Zoledronate—Paget's disease of bone	0.000134	0.00116	CcSEcCtD
Methotrexate—Diarrhoea—Risedronate—Paget's disease of bone	0.000134	0.00115	CcSEcCtD
Methotrexate—Asthenia—Pamidronate—Paget's disease of bone	0.000133	0.00115	CcSEcCtD
Methotrexate—Pruritus—Pamidronate—Paget's disease of bone	0.000132	0.00113	CcSEcCtD
Methotrexate—Dizziness—Risedronate—Paget's disease of bone	0.000129	0.00111	CcSEcCtD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000129	0.00889	CbGpPWpGaD
Methotrexate—Diarrhoea—Pamidronate—Paget's disease of bone	0.000127	0.0011	CcSEcCtD
Methotrexate—Hypersensitivity—Zoledronate—Paget's disease of bone	0.000125	0.00108	CcSEcCtD
Methotrexate—Vomiting—Risedronate—Paget's disease of bone	0.000124	0.00107	CcSEcCtD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000124	0.00853	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000124	0.00853	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—PML—Paget's disease of bone	0.000124	0.00853	CbGpPWpGaD
Methotrexate—Rash—Risedronate—Paget's disease of bone	0.000123	0.00106	CcSEcCtD
Methotrexate—Dermatitis—Risedronate—Paget's disease of bone	0.000123	0.00106	CcSEcCtD
Methotrexate—Dizziness—Pamidronate—Paget's disease of bone	0.000123	0.00106	CcSEcCtD
Methotrexate—Headache—Risedronate—Paget's disease of bone	0.000123	0.00106	CcSEcCtD
Methotrexate—Asthenia—Zoledronate—Paget's disease of bone	0.000122	0.00105	CcSEcCtD
Methotrexate—SLC22A11—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000121	0.00836	CbGpPWpGaD
Methotrexate—Pruritus—Zoledronate—Paget's disease of bone	0.00012	0.00104	CcSEcCtD
Methotrexate—SLC16A1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000119	0.0082	CbGpPWpGaD
Methotrexate—Vomiting—Pamidronate—Paget's disease of bone	0.000118	0.00102	CcSEcCtD
Methotrexate—Rash—Pamidronate—Paget's disease of bone	0.000117	0.00101	CcSEcCtD
Methotrexate—Dermatitis—Pamidronate—Paget's disease of bone	0.000117	0.00101	CcSEcCtD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000117	0.00809	CbGpPWpGaD
Methotrexate—Headache—Pamidronate—Paget's disease of bone	0.000117	0.001	CcSEcCtD
Methotrexate—Diarrhoea—Zoledronate—Paget's disease of bone	0.000116	0.001	CcSEcCtD
Methotrexate—Nausea—Risedronate—Paget's disease of bone	0.000116	0.001	CcSEcCtD
Methotrexate—FPGS—Disease—VCP—Paget's disease of bone	0.000116	0.00802	CbGpPWpGaD
Methotrexate—ABCC3—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000114	0.00789	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.000114	0.00785	CbGpPWpGaD
Methotrexate—Dizziness—Zoledronate—Paget's disease of bone	0.000112	0.000968	CcSEcCtD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000112	0.00772	CbGpPWpGaD
Methotrexate—Nausea—Pamidronate—Paget's disease of bone	0.00011	0.000952	CcSEcCtD
Methotrexate—SLC22A7—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.00011	0.00759	CbGpPWpGaD
Methotrexate—Vomiting—Zoledronate—Paget's disease of bone	0.000108	0.00093	CcSEcCtD
Methotrexate—ABCC4—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000107	0.00742	CbGpPWpGaD
Methotrexate—Rash—Zoledronate—Paget's disease of bone	0.000107	0.000923	CcSEcCtD
Methotrexate—Dermatitis—Zoledronate—Paget's disease of bone	0.000107	0.000922	CcSEcCtD
Methotrexate—Headache—Zoledronate—Paget's disease of bone	0.000106	0.000917	CcSEcCtD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000104	0.00721	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NUP205—Paget's disease of bone	0.000104	0.00721	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—OPTN—Paget's disease of bone	0.000102	0.00702	CbGpPWpGaD
Methotrexate—Nausea—Zoledronate—Paget's disease of bone	0.000101	0.000869	CcSEcCtD
Methotrexate—TYMS—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	9.92e-05	0.00685	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	9.36e-05	0.00647	CbGpPWpGaD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	9.23e-05	0.00638	CbGpPWpGaD
Methotrexate—ABCC2—NRF2 pathway—SQSTM1—Paget's disease of bone	9.06e-05	0.00625	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—VCP—Paget's disease of bone	9.04e-05	0.00625	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—OPTN—Paget's disease of bone	8.87e-05	0.00613	CbGpPWpGaD
Methotrexate—FPGS—Disease—NUP205—Paget's disease of bone	8.87e-05	0.00613	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—NUP205—Paget's disease of bone	8.74e-05	0.00603	CbGpPWpGaD
Methotrexate—PGD—Disease—VCP—Paget's disease of bone	8.27e-05	0.00571	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	8.2e-05	0.00566	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	8.08e-05	0.00558	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—CALCA—Paget's disease of bone	7.74e-05	0.00535	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	7.71e-05	0.00532	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—INPP5D—Paget's disease of bone	7.45e-05	0.00515	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—NUP205—Paget's disease of bone	7.43e-05	0.00513	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—NUP205—Paget's disease of bone	7.43e-05	0.00513	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—NUP205—Paget's disease of bone	7.22e-05	0.00499	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	7.05e-05	0.00487	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	7.01e-05	0.00484	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NUP205—Paget's disease of bone	6.91e-05	0.00477	CbGpPWpGaD
Methotrexate—FPGS—Disease—CALCA—Paget's disease of bone	6.58e-05	0.00455	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—INPP5D—Paget's disease of bone	6.33e-05	0.00438	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—INPP5D—Paget's disease of bone	6.33e-05	0.00438	CbGpPWpGaD
Methotrexate—PGD—Disease—NUP205—Paget's disease of bone	6.32e-05	0.00437	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—NUP205—Paget's disease of bone	6.3e-05	0.00435	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	6.15e-05	0.00425	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	6.03e-05	0.00417	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—INPP5D—Paget's disease of bone	5.94e-05	0.00411	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—NUP205—Paget's disease of bone	5.79e-05	0.004	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	5.58e-05	0.00386	CbGpPWpGaD
Methotrexate—MTHFR—Disease—VCP—Paget's disease of bone	5.46e-05	0.00377	CbGpPWpGaD
Methotrexate—AOX1—Disease—VCP—Paget's disease of bone	5.33e-05	0.00368	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	5.3e-05	0.00366	CbGpPWpGaD
Methotrexate—PGD—Metabolism—NUP205—Paget's disease of bone	5.29e-05	0.00366	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CALCA—Paget's disease of bone	5.13e-05	0.00354	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—INPP5D—Paget's disease of bone	4.93e-05	0.00341	CbGpPWpGaD
Methotrexate—DHFR—Disease—VCP—Paget's disease of bone	4.85e-05	0.00335	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	4.79e-05	0.00331	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	4.76e-05	0.00329	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	4.69e-05	0.00324	CbGpPWpGaD
Methotrexate—PGD—Disease—CALCA—Paget's disease of bone	4.69e-05	0.00324	CbGpPWpGaD
Methotrexate—PGD—Metabolism—INPP5D—Paget's disease of bone	4.51e-05	0.00312	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	4.5e-05	0.00311	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—INPP5D—Paget's disease of bone	4.43e-05	0.00306	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	4.29e-05	0.00296	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NUP205—Paget's disease of bone	4.17e-05	0.00288	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	4.17e-05	0.00288	CbGpPWpGaD
Methotrexate—AOX1—Disease—NUP205—Paget's disease of bone	4.07e-05	0.00281	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	4.01e-05	0.00277	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	3.97e-05	0.00274	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	3.92e-05	0.00271	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	3.79e-05	0.00262	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	3.75e-05	0.00259	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	3.74e-05	0.00258	CbGpPWpGaD
Methotrexate—DHFR—Disease—NUP205—Paget's disease of bone	3.71e-05	0.00256	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	3.56e-05	0.00246	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NUP205—Paget's disease of bone	3.49e-05	0.00241	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NUP205—Paget's disease of bone	3.41e-05	0.00236	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	3.36e-05	0.00232	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	3.3e-05	0.00228	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	3.2e-05	0.00221	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NUP205—Paget's disease of bone	3.1e-05	0.00214	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CALCA—Paget's disease of bone	3.1e-05	0.00214	CbGpPWpGaD
Methotrexate—AOX1—Disease—CALCA—Paget's disease of bone	3.02e-05	0.00209	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—INPP5D—Paget's disease of bone	2.98e-05	0.00206	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—INPP5D—Paget's disease of bone	2.91e-05	0.00201	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NUP205—Paget's disease of bone	2.83e-05	0.00195	CbGpPWpGaD
Methotrexate—DHFR—Disease—CALCA—Paget's disease of bone	2.75e-05	0.0019	CbGpPWpGaD
Methotrexate—ABCC1—Disease—VCP—Paget's disease of bone	2.74e-05	0.0019	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NUP205—Paget's disease of bone	2.71e-05	0.00187	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—INPP5D—Paget's disease of bone	2.65e-05	0.00183	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NUP205—Paget's disease of bone	2.48e-05	0.00172	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—INPP5D—Paget's disease of bone	2.41e-05	0.00166	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—INPP5D—Paget's disease of bone	2.31e-05	0.00159	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NUP205—Paget's disease of bone	2.24e-05	0.00155	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—INPP5D—Paget's disease of bone	2.12e-05	0.00146	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NUP205—Paget's disease of bone	2.1e-05	0.00145	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	2.04e-05	0.00141	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—INPP5D—Paget's disease of bone	2.01e-05	0.00139	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NUP205—Paget's disease of bone	1.95e-05	0.00135	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—INPP5D—Paget's disease of bone	1.91e-05	0.00132	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	1.83e-05	0.00126	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	1.78e-05	0.00123	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NUP205—Paget's disease of bone	1.76e-05	0.00121	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NUP205—Paget's disease of bone	1.67e-05	0.00115	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—INPP5D—Paget's disease of bone	1.66e-05	0.00115	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CALCA—Paget's disease of bone	1.56e-05	0.00108	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NUP205—Paget's disease of bone	1.55e-05	0.00107	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—INPP5D—Paget's disease of bone	1.5e-05	0.00103	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—INPP5D—Paget's disease of bone	1.42e-05	0.000983	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—INPP5D—Paget's disease of bone	1.32e-05	0.00091	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NUP205—Paget's disease of bone	9.54e-06	0.000659	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NUP205—Paget's disease of bone	8.35e-06	0.000577	CbGpPWpGaD
Methotrexate—ALB—Metabolism—INPP5D—Paget's disease of bone	8.13e-06	0.000562	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—INPP5D—Paget's disease of bone	7.12e-06	0.000492	CbGpPWpGaD
